 | Short Interest in Bellerophon Therapeutics Inc (NASDAQ:BLPH) Drops By 7.8%
www.americanbankingnews.com - February 15 at 12:34 PM |
| Bellerophon Therapeutics Inc (NASDAQ:BLPH) Expected to Announce Earnings of -$1.42 Per Share
www.americanbankingnews.com - February 14 at 2:48 PM |
| Bellerophon Therapeutics Stock Scheduled to Reverse Split on Monday, February 10th (NASDAQ:BLPH)
www.americanbankingnews.com - February 8 at 10:37 AM |
 | Bellerophon Announces 1-for-15 Reverse Stock Split
finance.yahoo.com - February 7 at 12:03 PM |
| Zacks: Bellerophon Therapeutics Inc (NASDAQ:BLPH) Given Consensus Rating of "Strong Buy" by Analysts
www.americanbankingnews.com - January 30 at 2:51 PM |
| Bellerophon Therapeutics Inc (NASDAQ:BLPH) Short Interest Update
www.americanbankingnews.com - January 29 at 4:38 AM |
 | Bellerophon Therapeutics, Inc. Common Stock (BLPH) Institutional Holdings
www.nasdaq.com - January 24 at 10:10 PM |
| Bellerophon Therapeutics Inc (NASDAQ:BLPH) Expected to Post Earnings of -$0.10 Per Share
www.americanbankingnews.com - January 22 at 10:44 PM |
 | BRIEF-Bellerophon Announces Positive Top-Line Results From Cohort 2 Of Phase 2/3 Study Of Inopulse
www.msn.com - December 17 at 11:01 PM |
 | Bellerophon +36% premarket on positive results from iNO-PF study
seekingalpha.com - December 17 at 1:01 PM |
| Bellerophon stock is up 35% on hypertension trial data
finance.yahoo.com - December 17 at 1:01 PM |
| Bellerophon Announces Positive Top-line Results from Cohort 2 of Phase 2/3 Study of INOpulse® for Treatment of Pulmonary Hypertension Associated with Interstitial Lung Disease
finance.yahoo.com - December 17 at 7:46 AM |
| Bellerophon Announces Positive Initial Data from Acute Hemodynamic Dose Escalation Study of INOpulse® for Treatment of Pulmonary Hypertension Associated with Interstitial Lung Disease
finance.yahoo.com - November 12 at 1:22 PM |
| Bellerophon Presents New Data from Cohort 1 of Ongoing Phase 2/3 Study of INOpulse® for Treatment of Pulmonary Hypertension Associated with Interstitial Lung Disease at Pulmonary Fibrosis Foundation Summit 2019
finance.yahoo.com - November 7 at 12:08 PM |
| Bellerophon Therapeutics EPS beats by $0.01
seekingalpha.com - November 6 at 3:46 PM |
| Bellerophon Provides Business Update and Reports Third Quarter 2019 Financial Results
finance.yahoo.com - November 6 at 3:46 PM |
| BLPH: More Clinical Data Supports Utility of INOpulse, Near-Term Value-Inflection Opportunities Grow
finance.yahoo.com - October 28 at 2:03 PM |
| Bellerophon Presents New Positive Data from Cohort 1 of Ongoing Phase 2/3 Study of INOpulse® for Treatment of Pulmonary Hypertension Associated with Interstitial Lung Disease at CHEST 2019 Annual Meeting
finance.yahoo.com - October 23 at 8:59 AM |
| Bellerophon to Present New Data from Cohort 1 of Ongoing Phase 2/3 Study of INOpulse® for Treatment of Pulmonary Hypertension Associated with Interstitial Lung Disease at CHEST 2019 Annual Meeting
finance.yahoo.com - October 14 at 8:31 AM |
| Bellerophon's nitric oxide an Orphan Drug in U.S. for IPF
seekingalpha.com - September 16 at 6:17 PM |
| Bellerophon Receives Orphan Drug Designation for Nitric Oxide in the Treatment of Idiopathic Pulmonary Fibrosis
finance.yahoo.com - September 16 at 6:16 PM |
| Bellerophon to Present at the H.C. Wainwright 21st Annual Global Investment Conference
finance.yahoo.com - September 4 at 9:46 AM |
| Bellerophon Therapeutics, Inc. (NASDAQ:BLPH) Insiders Increased Their Holdings
finance.yahoo.com - August 9 at 8:27 AM |
| Bellerophon Provides Business Update and Reports Second Quarter 2019 Financial Results
finance.yahoo.com - August 8 at 9:15 AM |
| BLPH: Zacks SCR Initiates Coverage of Bellerophon Therapeutics
finance.yahoo.com - August 7 at 12:01 AM |
| Bellerophon Completes Enrollment in Cohort 2 of Ongoing Phase 2/3 Study of INOpulse® for Treatment of Pulmonary Hypertension Associated with Interstitial Lung Disease
finance.yahoo.com - August 1 at 8:53 AM |
| Bellerophon to Present at the JMP Securities Life Sciences Conference
finance.yahoo.com - June 13 at 12:52 PM |
| Bellerophon to Host Key Opinion Leader Meeting Focused on Pulmonary Hypertension Associated with Interstitial Lung Disease
finance.yahoo.com - May 22 at 7:22 PM |
| Bellerophon Presents Additional Positive Data from Cohort 1 of Ongoing Phase 2/3 Study of INOpulse® for Treatment of Pulmonary Hypertension Associated with Interstitial Lung Disease at American Thoracic Society 115th International Conference
finance.yahoo.com - May 21 at 7:30 PM |
| Bellerophon to Present Additional Data from Cohort 1 of Ongoing Phase 2/3 Study of INOpulse® for Treatment of Pulmonary Hypertension Associated with Interstitial Lung Disease at American Thoracic Society 115th International Conference
finance.yahoo.com - May 13 at 7:59 PM |
| Bellerophon Provides Business Update and Reports First Quarter 2019 Financial Results
finance.yahoo.com - May 9 at 7:50 PM |
| Bellerophon Therapeutics: 1Q Earnings Snapshot
finance.yahoo.com - May 9 at 7:50 PM |
| What Kind Of Shareholders Own Bellerophon Therapeutics, Inc. (NASDAQ:BLPH)?
finance.yahoo.com - May 3 at 7:20 PM |
| Bellerophon Announces Agreement with FDA on Regulatory Approval Pathway for INOpulse® for Treatment of Pulmonary Hypertension Associated with Interstitial Lung Disease
finance.yahoo.com - April 8 at 7:54 PM |
| Bellerophon Therapeutics, Inc. Estimate Momentum
www.nasdaq.com - March 18 at 8:06 PM |
| Did Changing Sentiment Drive Bellerophon Therapeutics’s (NASDAQ:BLPH) Share Price Down A Painful 76%?
finance.yahoo.com - March 18 at 8:05 PM |
| Bellerophon Therapeutics, Inc. (BLPH)
finance.yahoo.com - March 14 at 7:23 PM |
| Bellerophon Provides Business Update and Reports Fourth Quarter and Full-Year 2018 Financial Results
finance.yahoo.com - March 14 at 7:23 PM |
| Bellerophon Therapeutics: 4Q Earnings Snapshot
finance.yahoo.com - March 14 at 7:23 PM |
| Bellerophon to Present Clinical Data Supporting Actigraphy as a Clinically Meaningful Endpoint to Detect Improvements in Pulmonary Fibrosis Patients
finance.yahoo.com - January 28 at 6:25 PM |
| Bellerophon closes $7M capital raise; shares up 6% after hours
seekingalpha.com - January 25 at 6:16 PM |
| Bellerophon Announces Closing of $7 Million Public Offering of Common Stock
finance.yahoo.com - January 25 at 6:16 PM |
 | Form 424B5 Bellerophon Therapeutics - StreetInsider.com
www.streetinsider.com - January 23 at 6:30 PM |
| Bellerophon Therapeutics (BLPH) Prices 10M Share Common Offering at $0.70/Sh - StreetInsider.com
www.streetinsider.com - January 23 at 6:30 PM |
 | Bellerophon Therapeutics, Inc. Announces Proposed Public Offering of Common Stock - GlobeNewswire
globenewswire.com - January 23 at 6:30 PM |
| Bellerophon prices $7M stock offering; shares down 25% premarket
seekingalpha.com - January 23 at 8:10 AM |
| Bellerophon Announces Pricing of $7 Million Public Offering of Common Stock
finance.yahoo.com - January 23 at 8:10 AM |
| Bellerophon down 7% after hours on stock offering
seekingalpha.com - January 22 at 6:28 PM |
| Bellerophon Therapeutics, Inc. Announces Proposed Public Offering of Common Stock
finance.yahoo.com - January 22 at 6:28 PM |
| Bellerophon Announces Top-line Results from Cohort 1 of the INOpulse® Phase 2b Clinical Trial for Treatment of Pulmonary Hypertension Associated with Interstitial Lung Disease
finance.yahoo.com - January 7 at 6:27 PM |
